National Health Investors, Inc. (NYSE:NHI) Receives $83.57 Consensus Target Price from Analysts

National Health Investors, Inc. (NYSE:NHIGet Free Report) has been given an average recommendation of “Moderate Buy” by the nine research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and six have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $82.25.

Several equities research analysts have issued reports on the stock. Truist Financial dropped their target price on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, September 2nd. Deutsche Bank Aktiengesellschaft decreased their price target on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Thursday, June 25th. Weiss Ratings restated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Finally, National Bank Financial set a $79.00 target price on shares of National Health Investors in a research report on Wednesday.

Get Our Latest Stock Report on National Health Investors

Insider Transactions at National Health Investors

In other National Health Investors news, Director Robert A. Mccabe, Jr. purchased 890 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the purchase, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.70% of the stock is currently owned by corporate insiders.

Institutional Trading of National Health Investors

Several hedge funds have recently added to or reduced their stakes in NHI. International Assets Investment Management LLC bought a new stake in National Health Investors in the fourth quarter valued at approximately $27,000. EverSource Wealth Advisors LLC grew its holdings in shares of National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in shares of National Health Investors in the fourth quarter worth $33,000. Allworth Financial LP purchased a new position in shares of National Health Investors in the second quarter worth $42,000. Finally, Advisory Services Network LLC purchased a new position in shares of National Health Investors in the third quarter worth $65,000. 62.51% of the stock is owned by institutional investors.

National Health Investors Price Performance

NYSE:NHI opened at $70.43 on Tuesday. The firm has a market capitalization of $3.46 billion, a price-to-earnings ratio of 20.36, a P/E/G ratio of 3.75 and a beta of 0.52. National Health Investors has a 52-week low of $67.94 and a 52-week high of $91.38. The stock has a fifty day moving average of $74.73 and a 200 day moving average of $77.55. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78.

National Health Investors (NYSE:NHIGet Free Report) last announced its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The business had revenue of $121.32 million for the quarter. During the same quarter in the prior year, the company earned $1.22 earnings per share. National Health Investors’s revenue was up 1.6% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, research analysts expect that National Health Investors will post 4.76 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors’s dividend payout ratio (DPR) is currently 106.36%.

About National Health Investors

(Get Free Report)

National Health Investors, Inc (NYSE:NHI) is a real estate investment trust that owns and finances healthcare real estate. The company focuses primarily on properties serving older adults and patients requiring specialized care, including independent living, assisted living, memory care, skilled nursing and continuing care retirement communities.

NHI generally leases its properties to healthcare and senior-living operators under long-term agreements, including primarily triple-net leases, under which tenants are typically responsible for property-level operating expenses, maintenance and taxes.

Featured Stories

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.